Drugs

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Drugs
Sep 15, 2024, 08:33 | Drugs
Paolo Tarantino: Some HER2+ tumors melt upon dual anti-HER2 Treatment
Paolo Tarantino shared on X: "Some HER2+ tumors melt upon dual anti-HER2 Treatment; others require…
Sep 7, 2024, 11:16 | Drugs
Paolo Tarantino: Recommended read on adjuvant ribociclib in preparation for the ESMO24
Oncology Brothers shared a post by Paolo Tarantino on X, adding: “Adjuvant abemaciclib preferred for…
Sep 7, 2024, 09:28 | Drugs
Elvina Almuradova: Doxorubicin with Trabectedin show promising results for patients with leiomyosarcoma
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on LinkedIn: "New findings published…
Sep 5, 2024, 15:06 | Drugs
Amol Akhade: Doxorubicin and Trabectedin followed by Trabectedin maintenance for leiomyosarcoma
Amol Akhade shared a post on LinkedIn: “Doxorubicin plus Trabectedin followed by Trabectedin maintenance for…
Sep 4, 2024, 07:45 | Drugs
Measuring Toxicity in Reproductive Organs during Oncology Drug Development – a FDA-ASCO Workshop
FDA Oncology shared on X: "Register now for Measuring Toxicity in Reproductive Organs during Oncology…
Aug 31, 2024, 17:49 | Drugs
Mark Lewis: From the first day of fellowship I was taught to “respect oxaliplatin"
Mark Lewis reshared a post on X by Erman Akkus, Medical Oncology Fellow at Ankara…
Aug 29, 2024, 16:15 | Drugs
Antonio Passaro: European Commission approves amivantamab
Antonio Passaro shared on LinkedIn: "I'm proud to announce that, yesterday August 27, the European…
Aug 27, 2024, 22:44 | Drugs
Yan Leyfman: Umoja Biopharma has developed an in situ CAR- therapy
Yan Leyfman shared on LinkedIn: "Umoja Biopharma CAR- therapy novel gene therapy approach to create CD19-directed…
Aug 27, 2024, 22:42 | Drugs
Maria Babak: Approval of axatilimab-csfr is a significant development in the treatment of cGVHD
Maria Babak shared a post by The Babak Lab on LinkedIn: "This is a significant…
Aug 23, 2024, 15:59 | Drugs
Aleix Prat: Our recent article on patritumab deruxtecan is on the list of Nature Communications' Editors’ Highlights
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
All: 396 Posts: 1 - 10
Special Coverage